DihydromikanolideCAS# 23758-04-5 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 23758-04-5 | SDF | Download SDF |
PubChem ID | 442200 | Appearance | Powder |
Formula | C15H16O6 | M.Wt | 292.28 |
Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R,4R,5S,7S,9S,12R,13R,14R)-7,12-dimethyl-3,6,10,15-tetraoxapentacyclo[12.2.1.02,4.05,7.09,13]heptadec-1(17)-ene-11,16-dione | ||
SMILES | CC1C2C(CC3(C(O3)C4C(O4)C5=CC2OC5=O)C)OC1=O | ||
Standard InChIKey | UOQXZMNXWXQCJU-XMOWUHPBSA-N | ||
Standard InChI | InChI=1S/C15H16O6/c1-5-9-7-3-6(14(17)18-7)10-11(20-10)12-15(2,21-12)4-8(9)19-13(5)16/h3,5,7-12H,4H2,1-2H3/t5-,7-,8+,9+,10-,11-,12+,15+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dihydromikanolide Dilution Calculator
Dihydromikanolide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4214 mL | 17.1069 mL | 34.2138 mL | 68.4275 mL | 85.5344 mL |
5 mM | 0.6843 mL | 3.4214 mL | 6.8428 mL | 13.6855 mL | 17.1069 mL |
10 mM | 0.3421 mL | 1.7107 mL | 3.4214 mL | 6.8428 mL | 8.5534 mL |
50 mM | 0.0684 mL | 0.3421 mL | 0.6843 mL | 1.3686 mL | 1.7107 mL |
100 mM | 0.0342 mL | 0.1711 mL | 0.3421 mL | 0.6843 mL | 0.8553 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2,6-Dihydroxyxanthone
Catalog No.:BCN9417
CAS No.:838-11-9
- Minisecolide C
Catalog No.:BCN9416
CAS No.:1967030-77-8
- Withaphysalin A
Catalog No.:BCN9415
CAS No.:57423-72-0
- Withaphysalin E
Catalog No.:BCN9414
CAS No.:118985-24-3
- Withaphysalin S
Catalog No.:BCN9413
CAS No.:949172-13-8
- Methyl (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate
Catalog No.:BCN9412
CAS No.:109837-85-6
- Physaminimin C
Catalog No.:BCN9411
CAS No.:1582259-03-7
- Physaminimin D
Catalog No.:BCN9410
CAS No.:1582259-05-9
- Hyperxanthone
Catalog No.:BCN9409
CAS No.:99481-41-1
- 5-Carboxystrictosidine
Catalog No.:BCN9408
CAS No.:34371-47-6
- 2,7-Dihydroxyxanthone
Catalog No.:BCN9407
CAS No.:64632-72-0
- Mumeose K
Catalog No.:BCN9406
CAS No.:2132384-01-9
- 4,5-Dihydropiperlonguminine
Catalog No.:BCN9419
CAS No.:23512-53-0
- Deoxymikanolide
Catalog No.:BCN9420
CAS No.:23753-57-3
- Macluraxanthone
Catalog No.:BCN9421
CAS No.:5848-14-6
- 4-Hydroxyxanthone
Catalog No.:BCN9422
CAS No.:14686-63-6
- 3-(Hydroxyacetyl)indole
Catalog No.:BCN9423
CAS No.:2400-51-3
- Minisecolide D
Catalog No.:BCN9424
CAS No.:1967030-78-9
- Lipodeoxyaconitine
Catalog No.:BCN9425
CAS No.:244190-83-8
- Lipoaconitine
Catalog No.:BCN9426
CAS No.:81941-14-2
- 3-epi-Dihydroscandenolide
Catalog No.:BCN9427
CAS No.:1137951-08-6
- cis-Shegansu B
Catalog No.:BCN9428
CAS No.:865474-99-3
- Methyl 2,4,6-trihydroxybenzoate
Catalog No.:BCN9429
CAS No.:3147-39-5
- Elatoside E
Catalog No.:BCN9430
CAS No.:156980-30-2
Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.[Pubmed:28945741]
PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005929.
Four sesquiterpene lactones, mikanolide, deoxymikanolide, Dihydromikanolide and scandenolide, were isolated by a bioassay-guided fractionation of Mikania variifolia and Mikania micrantha dichloromethane extracts. Mikanolide and deoxymikanolide were the major compounds in both extracts (2.2% and 0.4% for Mikania variifolia and 21.0% and 6.4% for Mikania micrantha respectively, calculated on extract dry weight). Mikanolide, deoxymikanolide and Dihydromikanolide were active against Trypanosoma cruzi epimastigotes (50% inhibitory concentrations of 0.7, 0.08 and 2.5 mug/mL, for each compound respectively). These sesquiterpene lactones were also active against the bloodstream trypomastigotes (50% inhibitory concentrations for each compound were 2.1, 1.5 and 0.3 mug/mL, respectively) and against amastigotes (50% inhibitory concentrations for each compound were 4.5, 6.3 and 8.5 mug/mL, respectively). By contrast, scandenolide was not active on Trypanosoma cruzi. Besides, mikanolide and deoxymikanolide were also active on Leishmania braziliensis promastigotes (50% inhibitory concentrations of 5.1 and 11.5 mug/mL, respectively). The four sesquiterpene lactones were tested for their cytotoxicity on THP 1 cells. Deoxymikanolide presented the highest selectivity index for trypomastigotes (SI = 54) and amastigotes (SI = 12.5). In an in vivo model of Trypanosoma cruzi infection, deoxymikanolide was able to decrease the parasitemia and the weight loss associated to the acute phase of the parasite infection. More importantly, while 100% of control mice died by day 22 after receiving a lethal T. cruzi infection, 70% of deoxymikanolide-treated mice survived. We also observed that this compound increased TNF-alpha and IL-12 production by macrophages, which could contribute to control T. cruzi infection.
Antimicrobial constituents of the leaves of Mikania micrantha H. B. K.[Pubmed:24098556]
PLoS One. 2013 Oct 2;8(10):e76725.
BACKGROUND: To isolate plant-derived compounds with antimicrobial activity from the leaves of Mikania micrantha, to determine the compounds configuration, and to evaluate their antimicrobial activity against eight plant pathogenic fungi (Exserohilum turcicum, Colletotrichum lagenarium, Pseudoperonispora cubensis, Botrytis cirerea, Rhizoctonia solani, Phytophthora parasitica, Fusarium solani, and Pythium aphanidermatum,) and four plant pathogenic bacteria (gram negative bacteria: Ralstonia dolaanacearum, Xanthomonas oryzae pv. Oryzae, Xanthomonas Campestris pv. Vesicatoria, and Xanthomonas campestris pv. Citri), and four bacteria (gram positive bacteria: Staphyloccocus aureus, Bacillus subtilis, Micrococcus luteus, and Bacillus cereus). METHODS AND RESULTS: Antimicrobial constituents of the leaves of M. micrantha were isolated using bioactivity- guided fractionation. The antifungal activity of the isolated compounds was evaluated by the inhibit hypha growth method and inhibit spore germination method. Characterization of antibacterial activity was carried out using the minimum inhibitory concentrations (MICs) and the minimum bactericidal concentrations (MBCs). MIC and MBC were determined by the broth microdilution method. Six compounds - deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, Dihydromikanolide, and m - methoxy benzoic acid - have been isolated from leaves of Mikania micrantha H. B. K. Deoxymikanolide, scandenolide, and dihydroscandenolide were new compounds. The result of bioassay showed that all of isolated compounds were effective against tested strains and deoxymikanolide showed the strongest activity. CONCLUSIONS AND SIGNIFICANCE: The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and the broadest range. Meanwhile, adverse impact of M. micrantha will be eliminated.
Antiviral constituents against respiratory viruses from Mikania micrantha.[Pubmed:19267453]
J Nat Prod. 2009 May 22;72(5):925-8.
Phytochemical investigation of the dried aerial parts of Mikania micrantha led to the isolation of a new sesquiterpene, 3beta-acetoxy-1,10-epoxy-4-germacrene-12,8;15,6-diolide (1), along with six known constituents: 1,10-epoxy-4-germacrene-12,8;15,6-diolide (2), Dihydromikanolide (3), potassium mikanin 3-sulfate (4), mikanin (5), alpinetin (6), and ergosta-7,22-dien-3beta-ol (7). Their structures were elucidated by spectroscopic methods, and the molecular structures and stereochemistry of sesquiterpene lactones 1-3 were revealed by single-crystal X-ray analysis. Compound 2 showed moderate activity against respiratory syncytial virus (IC(50) = 37.4 uM) and parainfluenza type 3 virus (IC(50) = 37.4 uM) with a therapeutic index (TI) of 16.0 for both compounds. Compound 4, the main component of M. micrantha, exhibited inhibitory activity against parainfluenza type 3 virus with IC(50) (19.7 uM) and TI (24.0) values comparable to those of ribavirin, serving as a positive control.
Potential allelochemicals from an invasive weed Mikania micrantha H.B.K.[Pubmed:16222800]
J Chem Ecol. 2005 Jul;31(7):1657-68.
Phytotoxicity-directed extraction and fractionation of the aerial parts of Mikania micrantha H.B.K. led to the isolation and identification of three sesquiterpenoids: Dihydromikanolide, deoxymikanolide, and 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide. These sesquiterpenoids inhibited both germination and seedling growth of tested species with deoxymikanolide possessing the strongest phytotoxicity. In a bioassay against lettuce (Lectuca sativa L.), deoxymikanolide reduced radicle elongation at low concentration (IC50 = 47 microg/ml); Dihydromikanolide showed a weaker effect (IC50 = 96 microg/ml), and 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide exhibited the least effect (IC50 = 242 microg/ml). Deoxymikanolide caused yellowish lesions at the root tips of lettuce at a concentration of 50 microg/ml, and a 250 microg/ml solution killed lettuce seedlings. A bioassay against the monocot ryegrass (Lolium multiforum) revealed similar results on radicle elongation, which implied that the growth inhibition by these compounds was not selective. To evaluate their phytotoxicity to plants in natural habitats, three common companion tree species in south China, Acacia mangium, Eucalyptus robusta, and Pinus massoniana, were also tested and similar results were obtained. This is the first report on the isolation of 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide as a naturally occurring product.
Analgesic sesquiterpene dilactone from Mikania cordata.[Pubmed:11731117]
Fitoterapia. 2001 Dec;72(8):919-21.
The crude extract of Mikania cordata (1 and 3 g/kg, p.o.) and deoxymikanolide (1) (10 mg/kg, p.o.) significantly inhibited acetic acid-induced writhing in mice. Three other sesquiterpene dilactones isolated from the same plant, namely mikanolide, Dihydromikanolide and scandenolide, did not show significant analgesic activity.
Investigation of plants used in Jamaican folk medicine for anti-bacterial activity.[Pubmed:10678503]
J Pharm Pharmacol. 1999 Dec;51(12):1455-60.
We have started a systematic scientific study of folklore medicinal plants currently used as alternative medicine in Jamaican society. In this initial study, extracts of plants widely used by the islanders are studied for antibacterial activity against five common pathogens; Streptococcus group A, Staphylococcus aureus, Proteus mirabilis, Pseudomonas aeruginosa and Escherichia coli. These studies revealed that 25% (approx.) of the plant extracts had antimicrobial activity against at least one of the microbes used. Subsequent to these observations, extracts from Mikania micrantha were examined in detail. This led to the isolation of two sesquiterpenoids, mikanolide and Dihydromikanolide, with activity against S. aureus and C. albicans. The results suggest that traditional folk medicine could be used as a guide in our continuing search for new natural products with potential medicinal properties.